BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 11202226)

  • 1. Hypothalamic growth hormone-insulin-like growth factor-I axis across the human life span.
    Ghigo E; Arvat E; Gianotti L; Lanfranco F; Broglio F; Aimaretti G; Maccario M; Camanni F
    J Pediatr Endocrinol Metab; 2000; 13 Suppl 6():1493-502. PubMed ID: 11202226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans.
    Gianotti L; Maccario M; Lanfranco F; Ramunni J; Di Vito L; Grottoli S; Muller EE; Ghigo E; Arvat E
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3604-8. PubMed ID: 11061509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human aging and the GH-IGF-I axis.
    Ghigo E; Arvat E; Gianotti L; Ramunni J; DiVito L; Maccagno B; Grottoli S; Camanni F
    J Pediatr Endocrinol Metab; 1996 Jun; 9 Suppl 3():271-8. PubMed ID: 8887170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone-releasing hormone and growth hormone-releasing peptide as therapeutic agents to enhance growth hormone secretion in disease and aging.
    Thorner MO; Chapman IM; Gaylinn BD; Pezzoli SS; Hartman ML
    Recent Prog Horm Res; 1997; 52():215-44; discussion 244-6. PubMed ID: 9238854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related growth hormone-releasing activity of growth hormone secretagogues in humans.
    Arvat E; Camanni F; Ghigo E
    Acta Paediatr Suppl; 1997 Nov; 423():92-6. PubMed ID: 9401552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with dilated cardiomyopathy show reduction of the somatotroph responsiveness to GHRH both alone and combined with arginine.
    Broglio F; Benso A; Gottero C; Vito LD; Aimaretti G; Fubini A; Arvat E; Bobbio M; Ghigo E
    Eur J Endocrinol; 2000 Feb; 142(2):157-63. PubMed ID: 10664524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of somatostatin infusion on the somatotrope responsiveness to growth hormone-releasing hormone in patients with anorexia nervosa.
    Gianotti L; Rolla M; Arvat E; Belliti D; Valetto MR; Ferdeghini M; Ghigo E; Müller EE
    Biol Psychiatry; 1999 Feb; 45(3):334-9. PubMed ID: 10023511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological regulation of the human growth hormone (GH)-insulin-like growth factor type I (IGF-I) axis: predominant impact of age, obesity, gonadal function, and sleep.
    Veldhuis JD; Iranmanesh A
    Sleep; 1996 Dec; 19(10 Suppl):S221-4. PubMed ID: 9085516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone in obesity.
    Scacchi M; Pincelli AI; Cavagnini F
    Int J Obes Relat Metab Disord; 1999 Mar; 23(3):260-71. PubMed ID: 10193871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
    Terzolo M; Bossoni S; Alí A; Doga M; Reimondo G; Milani G; Peretti P; Manelli F; Angeli A; Giustina A
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans.
    Ghigo E; Gianotti L; Arvat E; Ramunni J; Valetto MR; Broglio F; Rolla M; Cavagnini F; Müller EE
    J Clin Endocrinol Metab; 1999 Jan; 84(1):285-90. PubMed ID: 9920097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the growth hormone-insulin-like growth factor I axis in developing and adult monkeys is affected by estradiol replacement and supplementation with insulin-like growth factor I.
    Wilson ME
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2018-28. PubMed ID: 9626134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GH/IGF-I axis in anorexia nervosa.
    Gianotti L; Lanfranco F; Ramunni J; Destefanis S; Ghigo E; Arvat E
    Eat Weight Disord; 2002 Jun; 7(2):94-105. PubMed ID: 17644863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further evidence of cholinergic impairment of the neuroendocrine control of the GH secretion in Down's syndrome.
    Beccaria L; Marziani E; Manzoni P; Arvat E; Valetto MR; Gianotti L; Ghigo E; Chiumello G
    Dement Geriatr Cogn Disord; 1998; 9(2):78-81. PubMed ID: 9524798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone Plus arginine in children and adults with congenital hypopituitarism.
    Maghnie M; Salati B; Bianchi S; Rallo M; Tinelli C; Autelli M; Aimaretti G; Ghigo E
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1574-9. PubMed ID: 11297586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel relationships of age, visceral adiposity, insulin-like growth factor (IGF)-I and IGF binding protein concentrations to growth hormone (GH) releasing-hormone and GH releasing-peptide efficacies in men during experimental hypogonadal clamp.
    Veldhuis JD; Keenan DM; Bailey JN; Adeniji AM; Miles JM; Bowers CY
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2137-43. PubMed ID: 19351723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginine.
    Procopio M; Maccario M; Grottoli S; Oleandri SE; Boffano GM; Camanni F; Ghigo E
    Clin Endocrinol (Oxf); 1995 Dec; 43(6):665-9. PubMed ID: 8736266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone-releasing hormone.
    Bondanelli M; Ambrosio MR; Margutti A; Franceschetti P; Zatelli MC; degli Uberti EC
    Neuroendocrinology; 2003 Jun; 77(6):380-7. PubMed ID: 12845224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of GH/IGF-I axis in obesity by evaluation of IGF-I levels and the GH response to GHRH+arginine test.
    Maccario M; Gauna C; Procopio M; Di Vito L; Rossetto R; Oleandri SE; Grottoli S; Ganzaroli C; Aimaretti G; Ghigo E
    J Endocrinol Invest; 1999 Jun; 22(6):424-9. PubMed ID: 10435851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of beta-adrenergic agonists and antagonists on the growth hormone response to growth hormone-releasing hormone in anorexia nervosa.
    Gianotti L; Arvat E; Valetto MR; Ramunni J; Di Vito L; Maccagno B; Camanni F; Ghigo E
    Biol Psychiatry; 1998 Feb; 43(3):181-7. PubMed ID: 9494699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.